GMP Insiders

FDA Draft Guidance: Considerations for Complying with 21 CFR 211.110 FDA Highlights Systemic Issues at Mylan Laboratories in Recent Warning Flow Properties of Powders and Granules in Pharma Industry How to Write a Compliant SOP in the Pharma Industry? FDA Transitional Enforcement Guidance for Ethylene Oxide Sterilization Facility Changes for Class III Devices